Targeting host pathways to block HSV-1 at the cornea.
Department of Ophthalmology, University of Pittsburgh, Pittsburgh, Pennsylvania; kinchingtonp@upmc.edu.
Paul R
PR
Kinchington
D000287:Administration, Topical; D000818:Animals; D064007:Ataxia Telangiectasia Mutated Proteins / Q000037:antagonists & inhibitors / Q000378:metabolism; D002460:Cell Line; D004791:Enzyme Inhibitors / Q000494:pharmacology*; D019573:Epithelium, Corneal / Q000201:enzymology / Q000821:virology; D018259:Herpesvirus 1, Human / Q000502:physiology*; D006801:Humans; D016849:Keratitis, Herpetic / Q000201:enzymology / Q000517:prevention & control*; D051379:Mice; D009025:Morpholines / Q000494:pharmacology; D011753:Pyrones / Q000494:pharmacology; D011817:Rabbits; D014779:Virus Replication / Q000502:physiology
C495818:2-morpholin-4-yl-6-thianthren-1-yl-pyran-4-one; D004791:Enzyme Inhibitors; D009025:Morpholines; D011753:Pyrones; D064007:Ataxia Telangiectasia Mutated Proteins; C576325:Atm protein, mouse